Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0A0QL
|
||||
Former ID |
DIB018252
|
||||
Drug Name |
[3H]candesartan
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [541959] | ||
Formula |
C24H20N6O3
|
||||
InChI |
InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)
|
||||
InChIKey |
HTQMVQVXFRQIKW-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Type-1 angiotensin II receptor | Target Info | Antagonist | [525439] | |
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | Arf6 trafficking events | ||||
Arf6 signaling events | |||||
Angiopoietin receptor Tie2-mediated signaling | |||||
PathWhiz Pathway | Angiotensin Metabolism | ||||
Muscle/Heart Contraction | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.